Publication | Closed Access

Measurement of circulating transcripts and gene cluster analysis predicts and defines therapeutic efficacy of peptide receptor radionuclide therapy (PRRT) in neuroendocrine tumors

Tumor BiologyOncologyEngineeringMedicineRadionuclide TherapyPharmacologyNeuroendocrine DisorderPathologyCancer GenomicsRadiopharmaceutical TherapyNeuroendocrine TumorsMolecular DiagnosticsTumor MicroenvironmentNuclear MedicineCancer ResearchEndocrine-related CancerDefines Therapeutic Efficacy